Search research articles
Contact Us
Filters
Showing results (81-90 of 187) with videos related to
Page
of 19
Sort By:
European Journal of Endocrinology
|
January 2, 2008
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
Søren S Lund, Lise Tarnow, Merete Frandsen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
July 9, 2008
Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study
Frederik Persson, Peter Rossing, Peter Hovind, et al.
Diabetes Technology & Therapeutics
|
June 12, 2014
Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemia
Zeinab Mahmoudi, Morten Hasselstrøm Jensen, Mette Dencker Johansen, et al.
Clinical Proteomics
|
December 3, 2010
Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients
Anne Julie Overgaard, Tine E Thingholm, Martin R Larsen, et al.
Ugeskrift for Laeger
|
January 29, 2005
[Risk factors for the development of microalbuminuria in type 1 diabetes: an incidence cohort study--a secondary publication]
Peter Hovind, Lise Tarnow, Peter Rossing, et al.
Journal of Diabetes Science and Technology
|
May 31, 2014
Evaluation of an Algorithm for Retrospective Hypoglycemia Detection Using Professional Continuous Glucose Monitoring Data
Morten Hasselstrøm Jensen, Zeinab Mahmoudi, Toke Folke Christensen, et al.
Diabetes Care
|
December 24, 2005
Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy
Tri Q Nguyen, Lise Tarnow, Steen Andersen, et al.
Platelets
|
August 13, 2010
Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function
Maria Lajer, Inge Tarnow, Alan D Michelson, et al.
Kidney International
|
May 11, 2005
Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy
Steen Andersen, Frans A van Nieuwenhoven, Lise Tarnow, et al.
Proteome Science
|
March 9, 2010
Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy
Anne Julie Overgaard, Henning Gram Hansen, Maria Lajer, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 187) with videos related to
Sort By:
Page
of 19
European Journal of Endocrinology
|
January 2, 2008
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
Søren S Lund, Lise Tarnow, Merete Frandsen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
July 9, 2008
Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study
Frederik Persson, Peter Rossing, Peter Hovind, et al.
Diabetes Technology & Therapeutics
|
June 12, 2014
Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemia
Zeinab Mahmoudi, Morten Hasselstrøm Jensen, Mette Dencker Johansen, et al.
Clinical Proteomics
|
December 3, 2010
Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients
Anne Julie Overgaard, Tine E Thingholm, Martin R Larsen, et al.
Ugeskrift for Laeger
|
January 29, 2005
[Risk factors for the development of microalbuminuria in type 1 diabetes: an incidence cohort study--a secondary publication]
Peter Hovind, Lise Tarnow, Peter Rossing, et al.
Journal of Diabetes Science and Technology
|
May 31, 2014
Evaluation of an Algorithm for Retrospective Hypoglycemia Detection Using Professional Continuous Glucose Monitoring Data
Morten Hasselstrøm Jensen, Zeinab Mahmoudi, Toke Folke Christensen, et al.
Diabetes Care
|
December 24, 2005
Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy
Tri Q Nguyen, Lise Tarnow, Steen Andersen, et al.
Platelets
|
August 13, 2010
Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function
Maria Lajer, Inge Tarnow, Alan D Michelson, et al.
Kidney International
|
May 11, 2005
Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy
Steen Andersen, Frans A van Nieuwenhoven, Lise Tarnow, et al.
Proteome Science
|
March 9, 2010
Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy
Anne Julie Overgaard, Henning Gram Hansen, Maria Lajer, et al.
Page
of 19